Investigating the role of KARS in lung adenocarcinoma via single-cell RNA sequencing
Utilizing single-cell omics technologies, this research offers a detailed perspective on the role of KARS in LUAD, highlighting its potential as a prognostic biomarker and a candidate for tailored therapeutic intervention. Future research should probe possible therapeutic strategies that could target KARS in a pathologically relevant manner.
Authors
- Guangbiao Li
- Jung‐Yaw Lin (ORCID: https://orcid.org/0000-0002-6341-1160)
- Yonghong Li (ORCID: https://orcid.org/0000-0002-5085-1829)
- Yan Zhong (ORCID: https://orcid.org/0000-0002-6926-3584)
- Wei Wu (ORCID: https://orcid.org/0000-0002-5354-2634)
- Ru Deng (ORCID: https://orcid.org/0009-0007-6180-8387)
- Huafang Hu
Institutions
- Liuzhou Maternal and Child Health Hospital (CN)
- Liuzhou General Hospital (CN)
- Jingning County People's Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-12-03
- DOI
- https://doi.org/10.1007/s12672-024-01633-6
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00